Get started
Author

Rasmus Krøger Hare

Observed names: Hare, R, Hare, Rasmus Krøger, R Hare, R. K. Hare, R. Krøger Hare, R.K. Hare, Rasmus H. Jensen, Rasmus Hare, Rasmus Hare Jensen, Rasmus K. Hare, Rasmus Kroger Hare
ORCID: 0000-0002-9796-023X
Observed ORCID: 0000-0002-9796-023X
OpenAlex ID: A5040994420
Emergence of methicillin resistance predates the clinical use of antibiotics
2022 · Jesper Larsen, Claire L. Raisen, et al. · Nature · 307
PDF
Aspergillus Species and Other Molds in Respiratory Samples from Patients with Cystic Fibrosis: a Laboratory-Based Study with Focus on Aspergillus fumigatus Azole Resistance
2011 · Klaus Leth Mortensen, Rasmus Hare Jensen, et al. · Journal of Clinical Microbiology · 185
Emerging Terbinafine Resistance in Trichophyton : Clinical Characteristics, Squalene Epoxidase Gene Mutations, and a Reliable EUCAST Method for Detection
2019 · Ditte M. L. Saunte, Rasmus K. Hare, et al. · Antimicrobial Agents and Chemotherapy · 180
PDF
Update from a 12-Year Nationwide Fungemia Surveillance: Increasing Intrinsic and Acquired Resistance Causes Concern
2017 · K. M. T. Astvad, H. K. Johansen, et al. · Journal of Clinical Microbiology · 127
PDF
Differential In Vivo Activities of Anidulafungin, Caspofungin, and Micafungin against Candida glabrata Isolates with and without FKS Resistance Mutations
2012 · Maiken Cavling Arendrup, David S. Perlin, et al. · Antimicrobial Agents and Chemotherapy · 119
Molecular basis of antifungal drug resistance in yeasts
2017 · Florent Morio, Rasmus Hare Jensen, et al. · International Journal of Antimicrobial Agents · 116
Increasing Terbinafine Resistance in Danish Trichophyton Isolates 2019–2020
2022 · Karen Marie Thyssen Astvad, Rasmus Krøger Hare, et al. · Journal of Fungi · 114
PDF
In Vitro Activity of Isavuconazole and Comparators against Clinical Isolates of the Mucorales Order
2015 · Maiken Cavling Arendrup, Rasmus Hare Jensen, et al. · Antimicrobial Agents and Chemotherapy · 110
PDF
Stepwise emergence of azole, echinocandin and amphotericin B multidrug resistancein vivoinCandida albicansorchestrated by multiple genetic alterations
2015 · Rasmus Hare Jensen, Karen Marie Thyssen Astvad, et al. · Journal of Antimicrobial Chemotherapy · 98
PDF
Molecular diagnosis of dermatophyte infections
2012 · Rasmus H. Jensen, Maiken C. Arendrup · Current Opinion in Infectious Diseases · 91
EUCAST Determination of Olorofim (F901318) Susceptibility of Mold Species, Method Validation, and MICs
2018 · Karin Meinike Jørgensen, Karen M. T. Astvad, et al. · Antimicrobial Agents and Chemotherapy · 74
PDF
In Vitro Activity of Ibrexafungerp (SCY-078) against Candida auris Isolates as Determined by EUCAST Methodology and Comparison with Activity against C. albicans and C. glabrata and with the Activities of Six Comparator Agents
2019 · Maiken Cavling Arendrup, Karin Meinike Jørgensen, et al. · Antimicrobial Agents and Chemotherapy · 72
In Vivo Emergence of Aspergillus terreus with Reduced Azole Susceptibility and a Cyp51a M217I Alteration
2012 · Maiken C. Arendrup, Rasmus H. Jensen, et al. · The Journal of Infectious Diseases · 71
Candida palmioleophila: Characterization of a Previously Overlooked Pathogen and Its Unique Susceptibility Profile in Comparison with Five Related Species
2010 · Rasmus H. Jensen, Maiken C. Arendrup · Journal of Clinical Microbiology · 68
Rezafungin In Vitro Activity against Contemporary Nordic Clinical Candida Isolates and Candida auris Determined by the EUCAST Reference Method
2020 · Marie Helleberg, Karin Meinike Jørgensen, et al. · Antimicrobial Agents and Chemotherapy · 64
Interlaboratory evaluation of Mucorales PCR assays for testing serum specimens: A study by the fungal PCR Initiative and the Modimucor study group
2020 · S Rocchi, E Scherer, et al. · Medical Mycology · 61
In Vivo Selection of a Unique Tandem Repeat Mediated Azole Resistance Mechanism (TR120) inAspergillus fumigatus cyp51A, Denmark
2019 · Rasmus K. Hare, Jan B. Gertsen, et al. · Emerging infectious diseases · 55
PDF
The fading boundaries between patient and environmental routes of triazole resistance selection in Aspergillus fumigatus
2019 · Jochem B. Buil, Rasmus K. Hare, et al. · PLoS Pathogens · 53
PDF
Olorofim Susceptibility Testing of 1,423 Danish Mold Isolates Obtained in 2018-2019 Confirms Uniform and Broad-Spectrum Activity
2020 · Karen Marie Thyssen Astvad, Karin Meinike Jørgensen, et al. · Antimicrobial Agents and Chemotherapy · 52
Molecular epidemiology and in vitro antifungal susceptibility testing of 108 clinical Cryptococcus neoformans sensu lato and Cryptococcus gattii sensu lato isolates from Denmark
2016 · Ferry Hagen, Rasmus Hare Jensen, et al. · Mycoses · 51
Evaluation of the in vitro activity of isavuconazole and comparator voriconazole against 2635 contemporary clinical Candida and Aspergillus isolates
2017 · K.M.T. Astvad, R.K. Hare, et al. · Clinical Microbiology and Infection · 49
PDF
Stepwise Development of a Homozygous S80P Substitution in Fks1p, Conferring Echinocandin Resistance in Candida tropicalis
2012 · Rasmus Hare Jensen, Helle Krogh Johansen, et al. · Antimicrobial Agents and Chemotherapy · 47
Azole resistance in Aspergillus fumigatus. The first 2‐year's Data from the Danish National Surveillance Study, 2018–2020
2022 · Malene Risum, Rasmus Krøger Hare, et al. · Mycoses · 44
PDF
EUCAST Susceptibility Testing of Isavuconazole: MIC Data for Contemporary Clinical Mold and Yeast Isolates
2019 · Karin Meinike Jørgensen, Karen Marie Thyssen Astvad, et al. · Antimicrobial Agents and Chemotherapy · 44
PDF
Evaluation of Caspofungin Susceptibility Testing by the New Vitek 2 AST-YS06 Yeast Card Using a Unique Collection of FKS Wild-Type and Hot Spot Mutant Isolates, Including the Five Most Common Candida Species
2012 · Karen M. Astvad, David S. Perlin, et al. · Antimicrobial Agents and Chemotherapy · 44
PDF
Works count: 57
Citation count: 2,791
H-index: 31
I10-index: 45
Year
Topic
Type